Arsenic Trioxide Modulates Trk Receptor Expression in SK-N-SH Cells

Arsenic trioxide (As?O?) influences the expression of Trk receptors in SK-N-SH cells, key players in neuroblastoma progression. Treatment with As?O? alters the mRNA levels of TrkA, TrkB, and TrkC, indicating its potential to modulate signaling pathways involved in cell survival and differentiation. Understanding these effects may contribute to developing targeted therapies for neuroblastoma.